Published in Diabetes Care on May 01, 1999
Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al. Diabetes Care (1999) 1.08
When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study. Int J Clin Pract (2008) 0.90
Insulin lispro and retinopathy in pregnancy. Diabetes Care (1999) 0.75
Insulin lispro, pregnancy, and retinopathy. Diabetes Care (1999) 0.75
A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med (1992) 3.42
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Lysis-filtration blood culture versus conventional blood culture in a bacteremic rabbit model. J Clin Microbiol (1982) 2.98
Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care (1992) 2.90
Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89
Impacts of atmospheric anthropogenic nitrogen on the open ocean. Science (2008) 2.85
BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. J Clin Oncol (1999) 2.79
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA (1997) 2.78
Undue credit for supervisors. Nature (1994) 2.72
Isolation and characterization of the major protein and glycoprotein of hepatitis B surface antigen. J Biol Chem (1981) 2.60
Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res (1986) 2.38
Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol (1997) 2.35
Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1977) 2.34
The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol (1992) 1.95
Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J Mol Biol (1999) 1.93
Modified technique for efficient detection of microsporidia. J Clin Microbiol (1994) 1.90
Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A (1997) 1.78
Structure of hepatitis B surface antigen. Correlation of subtype with amino acid sequence and location of the carbohydrate moiety. J Biol Chem (1982) 1.78
Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J Biol Chem (1982) 1.69
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults : the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol (1999) 1.66
Transmission of human papillomaviruses from mother to child. Aust N Z J Obstet Gynaecol (1993) 1.63
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis (2001) 1.53
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet (1997) 1.53
The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol (1997) 1.48
Older women's experience of living with chronic leg ulceration. Int J Nurs Pract (1999) 1.47
Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients. Cancer J Sci Am (1998) 1.47
Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch Biochem Biophys (1995) 1.45
Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol (1996) 1.44
Fast-tracking (bypassing the PACU) does not reduce nursing workload after ambulatory surgery. Br J Anaesth (2004) 1.43
Mental health concerns of Canadian adolescents: a consumer's perspective. Can J Psychiatry (1996) 1.41
Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol (2007) 1.39
Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infect Immun (1997) 1.38
Primary structure of wheat germ agglutinin isolectin 2. Peptide order deduced from X-ray structure. Biochemistry (1984) 1.35
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer (2008) 1.34
Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein. Infect Immun (1990) 1.32
Immunobiology of the maternal-fetal relationship. Annu Rev Med (1979) 1.32
Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect Immun (1994) 1.31
beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. Int J Cancer (1999) 1.31
Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer (1997) 1.31
Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res (1997) 1.27
Molecular recognition between oligopeptides and nucleic acids: novel imidazole-containing oligopeptides related to netropsin that exhibit altered DNA sequence specificity. Biochemistry (1986) 1.26
Total Cystectomy with Transplantation of the Ureters into the Pelvic Colon for Malignant Growth of the Urinary Bladder: (Based on an Experience of Seven Successful Cases): (Section of Urology). Proc R Soc Med (1936) 1.25
Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev (2000) 1.24
The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern. J Biol Chem (1992) 1.22
A comparison of measured and calculated single- and double-stranded oligodeoxynucleotide extinction coefficients. Anal Biochem (1996) 1.21
Antigenic structure of hepatitis B surface antigen: identification of the "d" subtype determinant by chemical modification and use of monoclonal antibodies. J Immunol (1984) 1.21
Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol (1981) 1.20
The structure of hepatitis B surface antigen and its antigenic sites. Bioessays (1987) 1.19
Detection of HER2 amplification in circulating free DNA in patients with breast cancer. Br J Cancer (2011) 1.19
Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer (1995) 1.18
Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J Virol (1995) 1.18
Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients. AIDS (2000) 1.17
Resonance Raman detection of Fe-CO stretching and Fe-C-O bending vibrations in sterically hindered carbonmonoxy "strapped hemes". A structural probe of Fe-C-O distortion. Biochemistry (1983) 1.16
DNA cleavage specificity of a group of cationic metalloporphyrins. Biochemistry (1986) 1.15
Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis (1994) 1.14
Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol (2000) 1.13
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity. J Immunol (1985) 1.10
The role of complement in feline endotoxin shock. Am J Obstet Gynecol (1972) 1.10
Chronic fatigue syndrome in northern Nevada. Rev Infect Dis (1991) 1.10
Are we telling patients enough? A pilot study to assess patient information needs in a gastroenterology outpatient department. Eur J Gastroenterol Hepatol (1998) 1.10
ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producing peripheral blood lymphocytes in infected humans with and without cirrhosis. Clin Immunol (2001) 1.10
Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol (1978) 1.09
Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection. HIV Med (2013) 1.08
Mobile telephones interfere with medical electrical equipment. Australas Phys Eng Sci Med (1994) 1.08
Epitopes recognized by antibodies to denatured core protein of hepatitis B virus. Mol Immunol (1993) 1.07
Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J Virol (2001) 1.06
FMD control strategies. Vet Rec (2001) 1.06
Phospholipid interactions of the putative fusion peptide of hepatitis B virus surface antigen S protein. J Gen Virol (1995) 1.05
Esperamicins, a class of potent antitumor antibiotics: mechanism of action. Proc Natl Acad Sci U S A (1989) 1.05
Immunofluorescent study of placental bed vessels in pre-eclampsia of pregnancy. Am J Obstet Gynecol (1973) 1.03
A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer. J Clin Oncol (1986) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
Genetic susceptibility to colorectal cancer in patients under 45 years of age. Br J Surg (1994) 1.01
The hepatitis nucleocapsid as a vaccine carrier moiety. Ann N Y Acad Sci (1995) 1.01
A biological classification of progestational agents. Fertil Steril (1967) 1.00
An increase in Haemophilus influenzae type B vaccination among preschool-aged children in inner-city Los Angeles, 1990 through 1992. Am J Public Health (1994) 0.99
Mid-frequency loss of foveal flicker sensitivity in early stages of age-related maculopathy. Invest Ophthalmol Vis Sci (1992) 0.98
The role of intravascular coagulation in feline endotoxin shock. Surg Gynecol Obstet (1972) 0.97
The infant of the diabetic mother: correlation of increased cord C-peptide levels with macrosomia and hypoglycemia. N Engl J Med (1979) 0.97
DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol (1999) 0.96
The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients. J Med Genet (2005) 0.96
Statistical comparison of residential soil concentrations of PCDDs, PCDFs, and PCBs from two communities in Michigan. Environ Sci Technol (2008) 0.96
The chemistry of vitamin B 12. The co-ordination of biologically important molecules. Biochem J (1970) 0.96
Long-term consequences of intracranial haemorrhage in children with haemophilia. Haemophilia (2008) 0.96
Cancer of the cervix--old and young, now and then. Gynecol Oncol (1991) 0.96
Serum complement in normal pregnancy and pre-eclampsia. Am J Obstet Gynecol (1973) 0.96
Obstetric complications with GDM. Effects of maternal weight. Diabetes (1991) 0.96
DNA binding specificity of a series of cationic metalloporphyrin complexes. Biochemistry (1986) 0.95
Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Oncogene (1996) 0.95
Site-specific binding constants for actinomycin D on DNA determined from footprinting studies. Biochemistry (1992) 0.95
Measurement of the strong coupling constant from inclusive jet production at the Tevatron pp collider. Phys Rev Lett (2002) 0.94
Quantitative footprinting analysis using a DNA-cleaving metalloporphyrin complex. Biochemistry (1989) 0.94
Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Am J Hum Genet (1994) 0.94
Increased depth of trophoblast invasion after chronic constriction of the lower aorta in rhesus monkeys. Am J Obstet Gynecol (1993) 0.93
Search for gluinos and scalar quarks in pp collisions at square root[s] = 1.8 TeV using the missing energy plus multijets signature. Phys Rev Lett (2002) 0.93
HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Hum Immunol (2000) 0.93
Measles surveillance: guidelines for laboratory support. Working Group on Measles Elimination. Can Commun Dis Rep (1998) 0.93
Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol (1995) 0.93
Cloning, expression, isolation and characterization of the pre-S domains of hepatitis B surface antigen, devoid of the S protein. Biochem J (1991) 0.92